📰 Danielj Starks News
Page 2 - Danielj Starks News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Danielj Starks. Real-time updates on events, politics, business and more.
January 24, 2024
EverSource Wealth Advisors LLC reduced its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 1.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 21,369 shares of the healthcare product maker’s stock after selling 241 shares during the quarter. EverSource […]
January 24, 2024
Winthrop Advisory Group LLC cut its position in Abbott Laboratories (NYSE:ABT – Free Report) by 6.0% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 2,304 shares of the healthcare product maker’s stock after selling 147 shares during the quarter. Winthrop Advisory Group LLC’s holdings in Abbott Laboratories were worth $223,000 as of its […]
January 24, 2024
Winthrop Advisory Group LLC trimmed its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 6.0% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,304 shares of the healthcare product maker’s stock after selling 147 shares during the quarter. Winthrop Advisory […]
January 24, 2024
Briaud Financial Planning Inc bought a new position in shares of Abbott Laboratories (NYSE:ABT – Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 500 shares of the healthcare product maker’s stock, valued at approximately $48,000. Other hedge […]
January 23, 2024
NewSquare Capital LLC reduced its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 52.8% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 464 shares of the healthcare product maker’s stock after selling 520 shares during the quarter. NewSquare Capital LLC’s holdings in Abbott […]
January 23, 2024
Fortis Capital Management LLC bought a new position in Abbott Laboratories (NYSE:ABT – Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 14,209 shares of the healthcare product maker’s stock, valued at approximately $1,376,000. A number of […]
January 23, 2024
Nomura Asset Management Co. Ltd. raised its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 6.7% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,103,069 shares of the healthcare product maker’s stock after acquiring an additional 68,897 shares during […]
January 23, 2024
Signaturefd LLC lessened its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 3.0% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 41,241 shares of the healthcare product maker’s stock after selling 1,277 shares during the quarter. Signaturefd […]
January 23, 2024
Camden National Bank cut its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 3.3% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,486 shares of the healthcare product maker’s stock after selling 151 shares during the period. Camden National […]
January 22, 2024
Bahl & Gaynor Inc. lessened its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 17.3% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 2,069,348 shares of the healthcare product maker’s stock after selling 433,068 shares during the period. Abbott Laboratories accounts […]